{"id":2022,"date":"2025-04-07T07:43:04","date_gmt":"2025-04-07T14:43:04","guid":{"rendered":"http:\/\/www.fcihr.ca\/prize\/?page_id=2022"},"modified":"2025-04-30T12:46:36","modified_gmt":"2025-04-30T19:46:36","slug":"dr-brenda-andrews-2025-friesen-prize","status":"publish","type":"page","link":"https:\/\/www.fcihr.ca\/prize\/dr-brenda-andrews-2025-friesen-prize","title":{"rendered":"Dr. Brenda Andrews, 2025 Friesen Prize"},"content":{"rendered":"

Title of Talk – Dr. Brenda Andrews – 2025 Friesen Prize:<\/strong>
\n“Accelerating Discovery: The Catalytic Impact
\nof Interdisciplinary Environments on Basic Biomedical Research”<\/i><\/span><\/span><\/strong><\/p>\n

Click here to Download Brief Bio – Dr. Brenda Andrews<\/a><\/p>\n

\"\"<\/a><\/p>\n

CONGRATULATIONS,
\nDR. BRENDA ANDREWS<\/span><\/span><\/strong><\/p>\n

Friends of CIHR is pleased to announce that Dr. Brenda Andrews, C.C., PhD, FRSC, pioneer in systems biology & Founding Director of Donnelly Centre, a leading multidisciplinary systems biology institute, is the recipient of the 2025 Henry G. Friesen International Prize in Health Research.<\/strong><\/p>\n

Toronto \u2013 March 29, 2025 \u2013 Dr Brenda Andrews, C.C., PhD, FRSC, is an internationally renowned geneticist recognized for her functional genomics work in the budding yeast model system. She is known particularly for her studies on cell cycle-regulated transcription and protein kinase function in yeast and for pioneering work with Charles Boone on genetic networks. This fundamental research established the power of systematic genetics for illuminating the roles of genes and their corresponding pathways and the importance of genetic interactions in cellular function, both in health and disease. Dr. Andrews\u2019 leadership skills, as the inaugural Director of the Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto (2004-2020), established the Donnelly Centre as a premiere institute internationally for interdisciplinary biomedical research and has helped solidify Canada\u2019s reputation as a leader in post-genome biology and the emerging field of personalized medicine. In parallel with her service as Donnelly Director, Dr Andrews held an appointment as Chair of the Banting and Best Department of Medical Research (BBDMR), which was integrated with the Donnelly Centre as part of a vision to create a collaborative environment to catalyze foundational biomedical research, technological innovation and clinical impact.<\/p>\n

Born in Clinton, Ontario (Canada), Dr Andrews obtained a BSc and PhD at the University of Toronto, then pursued postdoctoral training in genetics with the late Dr. Ira Herskowitz at the University of California San Francisco. In 1991, Dr. Andrews was recruited to the Department of Medical Genetics (now Molecular Genetics) at the University of Toronto. She became Chair of the Department in 1999, a position she held for 5 years before assuming her positions as Chair of the BBDMR and as Director of the Donnelly Centre. She continued as Director of the Donnelly Centre and Charles H Best Chair of Medical Research until 2020 and was named a University Professor in 2017.<\/p>\n

Dr. Andrews is a passionate mentor, who developed a merged molecular genetics and microbiology undergraduate curriculum as Chair of the Molecular Genetics Department, and has supervised dozens of graduate and postgraduate students, who now hold positions in academia, industry, education and research administration. Together with her collaborators and lab members, she has published over 236 peer-reviewed articles in top journals and has presented her work at many institutions and meetings worldwide. She has also served on numerous advisory boards and review panels, including as founding editor-in-chief of Genes|Genomes|Genetics (G3), an open access journal of the Genetics Society of America, Chair of the Scientific Advisory Board of the European Molecular Biology Laboratory (EMBL), Chair of the Burroughs Wellcome Fund Board of Directors, and Member of the Governing Council of the Canadian Institutes for Health Research (CIHR).<\/p>\n

Dr. Andrews is a Companion of the Order of Canada, an elected Fellow of the Royal Society of Canada, the American Association for the Advancement of Science and the American Academy of Microbiology, and an International Member of the National Academy of Sciences (USA).<\/p>\n

The Henry G. Friesen International Prize in Health Research, established in 2005 by the Friends of Canadian Institutes of Health Research (FCIHR), recognizes exceptional innovation by a visionary health leader of international stature. The $35,000 Friesen Prize is awarded annually. Dr. Brenda Andrews will deliver public talks in 2025 in conjunction with the Friesen Prize Program. For further information on Friends of CIHR and the Friesen International Prize, please visit: www.fcihr.ca or contact: Cristina S. Castellvi.<\/p>\n

Tel. #: (416) 978-6759. Email: FriendsofCIHR@gmail.com<\/a><\/p>\n

\n

\"\"<\/a><\/p>\n

Les Amis des IRSC sont heureux d’annoncer que :
\nla Dre Brenda Andrews, C.C., Ph. D., FRSC, pionni\u00e8re en biologie des syst\u00e8mes et directrice fondatrice de l\u2019institut multidisciplinaire de biologie des syst\u00e8mes de premier plan Donnelly Centre, est la laur\u00e9ate du Prix international Henry G. Friesen de recherche en sant\u00e9 2025.<\/strong><\/p>\n

Toronto \u2013 Le 29 mars 2025 \u2013 La Dre Brenda Andrews, C.C., Ph. D., FRSC, est une g\u00e9n\u00e9ticienne de renomm\u00e9e internationale, reconnue pour ses travaux de g\u00e9nomique fonctionnelle dans le syst\u00e8me mod\u00e8le de levure bourgeonnante. Elle est particuli\u00e8rement connue pour ses \u00e9tudes en transcription r\u00e9gul\u00e9e par le cycle cellulaire et dans la fonction des prot\u00e9ines kinases de la levure, et pour son r\u00f4le de pionni\u00e8re en r\u00e9seaux g\u00e9n\u00e9tiques avec Charles Boone. Cette recherche fondamentale a \u00e9tabli le pouvoir de la g\u00e9n\u00e9tique syst\u00e9matique pour mettre en lumi\u00e8re les r\u00f4les des g\u00e8nes et leurs voies correspondantes ainsi que l’importance des interactions g\u00e9n\u00e9tiques dans la fonction cellulaire, \u00e0 la fois en mati\u00e8re de sant\u00e9 et de maladie. Les comp\u00e9tences de meneuse de la Dre Andrews, comme premi\u00e8re directrice du Donnelly Centre for Cellular and Biomolecular Research de l’Universit\u00e9 de Toronto (2004-2020) ont hiss\u00e9 ce centre au premier plan \u00e0 l’\u00e9chelle internationale pour la recherche biom\u00e9dicale interdisciplinaire et ont contribu\u00e9 \u00e0 consolider la r\u00e9putation du Canada comme chef de file en biologie post-g\u00e9nomique et dans le domaine \u00e9mergent de la m\u00e9decine personnalis\u00e9e. Outre son poste de directrice du Centre Donnelly, la Dre Andrews a \u00e9t\u00e9 nomm\u00e9e \u00e0 la t\u00eate du D\u00e9partement de recherche m\u00e9dicale Banting et Best (BBDMR), qui a \u00e9t\u00e9 int\u00e9gr\u00e9 au Centre Donnelly dans le cadre de la vision de cr\u00e9er un environnement collaboratif afin de catalyser la recherche biom\u00e9dicale fondamentale, l’innovation technologique et l’impact clinique.<\/p>\n

N\u00e9e \u00e0 Clinton, en Ontario (Canada), la Dre Andrews a vu l’Universit\u00e9 de Toronto lui d\u00e9cerner un baccalaur\u00e9at en sciences et un doctorat, puis elle a poursuivi une formation postdoctorale en g\u00e9n\u00e9tique avec la regrett\u00e9e Dre Ira Herskowitz \u00e0 l’Universit\u00e9 de Californie \u00e0 San Francisco. En 1991, la Dre Andrews a \u00e9t\u00e9 embauch\u00e9e au D\u00e9partement de g\u00e9n\u00e9tique m\u00e9dicale (aujourd\u2019hui g\u00e9n\u00e9tique mol\u00e9culaire) de l’Universit\u00e9 de Toronto. Elle en est devenue directrice en 1999, poste qu’elle a occup\u00e9 pendant 5 ans avant d’assumer ses fonctions de pr\u00e9sidente du BBDMR et de directrice du Centre Donnelly, poste qu\u2019elle a continu\u00e9 d’occuper tout comme celui de directrice de la chaire de recherche m\u00e9dicale Charles H Best jusqu’en 2020. Elle a \u00e9t\u00e9 nomm\u00e9e professeure d’universit\u00e9 en 2017.<\/p>\n

La mentor passionn\u00e9e qu\u2019est la Dre Andrews a \u00e9labor\u00e9 un programme d’\u00e9tudes de premier cycle en g\u00e9n\u00e9tique mol\u00e9culaire et en microbiologie \u00e0 titre de directrice du D\u00e9partement de g\u00e9n\u00e9tique mol\u00e9culaire et elle a supervis\u00e9 des dizaines d’\u00e9tudiants des cycles sup\u00e9rieurs et plus \u00e9lev\u00e9s, qui occupent maintenant des postes dans le milieu universitaire, l’industrie, l’\u00e9ducation et l’administration de la recherche. Avec ses collaborateurs et les membres de son laboratoire, elle a publi\u00e9 plus de 236 articles \u00e9valu\u00e9s par les pairs dans des revues de premier plan et elle a pr\u00e9sent\u00e9 ses travaux dans de nombreuses institutions et groupes du monde entier. Elle a \u00e9galement si\u00e9g\u00e9 \u00e0 de nombreux conseils consultatifs et comit\u00e9s d’examen, notamment en tant que r\u00e9dactrice en chef fondatrice de Genes|G\u00e9nomes|Genetics (G3), revue en libre acc\u00e8s de la Genetics Society of America, pr\u00e9sidente du conseil consultatif scientifique du Laboratoire europ\u00e9en de biologie mol\u00e9culaire (EMBL), pr\u00e9sidente du conseil d’administration du Burroughs Wellcome Fund et membre du conseil d’administration des Instituts de recherche en sant\u00e9 du Canada (IRSC).<\/p>\n

La Dre Andrews est Compagnon de l’Ordre du Canada, membre \u00e9lue de la Soci\u00e9t\u00e9 royale du Canada, de l’American Association for the Advancement of Science et de l’American Academy of Microbiology, et membre internationale de la National Academy of Sciences (\u00c9tats-Unis).<\/p>\n

Le Prix international Henry G. Friesen de la recherche en sant\u00e9, cr\u00e9\u00e9 en 2005 par les Amis des Instituts de recherche en sant\u00e9 du Canada (IRSC), reconna\u00eet l’innovation exceptionnelle d’un chef de file visionnaire en sant\u00e9 d’envergure internationale. Le prix Friesen, d’une valeur de 35 000 $, est d\u00e9cern\u00e9 chaque ann\u00e9e. La Dre Brenda Andrews donnera des conf\u00e9rences publiques en 2025 dans le cadre du programme du prix Friesen. Pour de plus amples renseignements sur les Amis des IRSC et le Prix international Friesen, pri\u00e8re de consulter le site www.fcihr.ca ou communiquer avec Mlle Cristina S. Castellvi.<\/p>\n

T\u00e9l. # : (416) 978-6759. Courriel : FriendsofCIHR@gmail.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Title of Talk – Dr. Brenda Andrews – 2025 Friesen Prize: “Accelerating Discovery: The Catalytic Impact of Interdisciplinary Environments on Basic Biomedical Research” Click here to Download Brief Bio – Dr. Brenda Andrews CONGRATULATIONS, DR. BRENDA ANDREWS Friends of CIHR is pleased to announce that Dr. Brenda Andrews, C.C., PhD, FRSC, pioneer in systems biology […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2022","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/pages\/2022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/comments?post=2022"}],"version-history":[{"count":9,"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/pages\/2022\/revisions"}],"predecessor-version":[{"id":2038,"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/pages\/2022\/revisions\/2038"}],"wp:attachment":[{"href":"https:\/\/www.fcihr.ca\/prize\/wp-json\/wp\/v2\/media?parent=2022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}